4Front Ventures (FFNTF) 10-Q 17 Aug 21 2021 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2021	Aug. 13, 2021
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--12-31
Entity File Number	000-56075
Entity Registrant Name	4Front Ventures Corp.
Entity Incorporation, State or Country Code	A1
Entity Tax Identification Number	83-4168417
Entity Address, Address Line One	5060 N. 40th Street
Entity Address, Address Line Two	Suite 120
Entity Address, City or Town	Phoenix
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85018
City Area Code	602
Local Phone Number	633-3067
Trading Symbol	FFNT
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	false
Entity Ex Transition Period	false
Entity Common Stock Shares Outstanding		592,627,966
Entity Central Index Key	0001783875
Amendment Flag	false
Class A Subordinate Voting Shares
Document Information [Line Items]
Trading Symbol	FFNTF
Title of 12(g) Security	Class A Subordinate Voting Shares, no par value

Condensed Consolidated Interim

Condensed Consolidated Interim Balance Sheets (unaudited) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Current assets:
Cash	$ 11,563	$ 18,932
Accounts receivable	917	437
Other receivables	583	1,341
Current portion of lease receivables	3,540	3,450
Inventory	22,600	18,037
Current portion of notes receivable	235	264
Prepaid expenses	2,225	2,275
Total current assets	41,663	44,736
Property and equipment, net	44,270	33,618
Notes receivable and accrued interest		91
Lease receivables	7,156	7,595
Intangible assets, net	27,524	28,790
Goodwill	23,155	23,155
Right-of-use assets	60,701	62,466
Deposits	4,295	4,305
TOTAL ASSETS	208,764	204,756
Current liabilities:
Accounts payable	5,484	4,722
Accrued expenses and other current liabilities	5,569	6,427
Taxes payable	16,665	11,502
Derivative liability	7,223	5,807
Current portion of convertible notes	2,420	1,652
Current portion of lease liability	1,127	1,909
Current portion of contingent consideration payable	3,316	2,393
Current portion of notes payable and accrued interest	4,119	3,372
Total current liabilities	45,923	37,784
Convertible notes		14,722
Notes payable and accrued interest from related party	46,843	45,362
Long term notes payable	1,819	1,907
Long term accounts payable	1,600	1,600
Contingent consideration payable		3,103
Deferred tax liability	7,162	6,530
Lease liability	51,849	51,545
TOTAL LIABILITIES	155,196	162,553
SHAREHOLDERS' EQUITY
Equity attributable to 4Front Ventures Corp.	273,875	250,583
Additional paid-in capital	47,491	42,116
Deficit	(267,860)	(250,548)
Total 4Front Ventures Corp. shareholders' equity	53,506	42,151
Non-controlling interest	62	52
TOTAL SHAREHOLDERS' EQUITY	53,568	42,203
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 208,764	$ 204,756

Condensed Consolidated Interi_2

Condensed Consolidated Interim Statements of Operations and Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
REVENUE
Revenue from sale of goods	$ 24,452	$ 9,967	$ 44,532	$ 19,722
Real estate income	2,669	2,734	5,559	5,631
Total revenues	27,121	12,701	50,091	25,353
Cost of goods sold	(10,816)	(8,046)	(19,941)	(12,695)
Gross profit	16,305	4,655	30,150	12,658
OPERATING EXPENSES
Selling and marketing expenses	6,714	5,488	11,871	12,304
General and administrative expenses	5,083	3,073	10,248	8,181
Equity based compensation	2,979	1,048	5,375	2,275
Depreciation and amortization	861	975	1,635	1,888
Total operating expenses	15,637	10,584	29,129	24,648
Income (loss) from operations	668	(5,929)	1,021	(11,990)
Other income (expense)
Interest income	8	8	11	64
Interest expense	(2,901)	(4,877)	(5,362)	(7,013)
Amortization of loan discount upon conversion of debt to equity			(2,915)
Change in fair value of derivative liability	(311)		(2,843)
Other income		2,682		2,719
Loss on lease termination	(331)		(1,210)
Total other income (expense)	(3,535)	(2,187)	(12,319)	(4,230)
Net loss before income taxes	(2,867)	(8,116)	(11,298)	(16,220)
Income tax expense	(3,351)	(2,373)	(6,004)	(2,923)
Net loss from continuing operations, net of taxes	(6,218)	(10,489)	(17,302)	(19,143)
Net income from discontinued operations, net of taxes		9,840		10,712
Net loss	(6,218)	(649)	(17,302)	(8,431)
Net (income) loss attributable to non-controlling interest	5	(38)	10	(26)
Net loss attributable to shareholders	$ (6,223)	$ (611)	$ (17,312)	$ (8,405)
Basic and diluted loss per share	$ (0.01)	$ 0	$ (0.03)	$ (0.02)
Weighted average number of shares outstanding, basic and diluted	587,218,794	506,379,437	573,108,183	518,950,529

Condensed Consolidated Interi_3

Condensed Consolidated Interim Statements of Changes in Shareholders' Equity (unaudited) - USD ($) $ in Thousands	Total	Pure Ratios	Om of Medicine	Share Capital	Share CapitalPure Ratios	Share CapitalOm of Medicine	Additional Paid-In Capital	Deficit	Total 4Front Ventures Corp. Shareholders' Equity	Total 4Front Ventures Corp. Shareholders' EquityPure Ratios	Total 4Front Ventures Corp. Shareholders' EquityOm of Medicine	Non-Controlling Interest
Beginning Balance at Dec. 31, 2019	$ 74,760			$ 252,656			$ 25,618	$ (203,497)	$ 74,777			$ (17)
Beginning Balance, Shares at Dec. 31, 2019				531,522,819
Conversion option and warrants with notes transferred to equity	411						411		411
Shares issued for earnout		$ 94			$ 94					$ 94
Shares issued for earnout, shares					223,145
Share-based compensation	2,275						2,275		2,275
Conversion of notes to equity	2,889						2,889		2,889
Exchange of stock for convertible swap notes	(13,661)			$ (13,661)					(13,661)
Exchange of stock for convertible swap notes, shares				(29,448,468)
Net loss	(8,431)							(8,405)	(8,405)			(26)
Ending Balance at Jun. 30, 2020	58,337			$ 239,089			31,193	(211,902)	58,380			(43)
Ending Balance, Shares at Jun. 30, 2020				502,297,496
Beginning Balance at Dec. 31, 2020	42,203			$ 250,583			42,116	(250,548)	42,151			52
Beginning Balance, Shares at Dec. 31, 2020				538,851,252
Shares issued for earnout		$ 161	$ 722		$ 161	$ 722				$ 161	$ 722
Shares issued for earnout, shares					473,491	535,018
Share-based compensation	5,375						5,375		5,375
Conversion of notes to equity	17,719			$ 17,719					17,719
Conversion of notes to equity, shares				49,042,797
Shares issued with exercise of stock options	$ 1,314			$ 1,314					1,314
Shares issued with exercise of stock options, shares	2,011,056			2,011,056
Shares issued with exercise of warrants	$ 3,376			$ 3,376					3,376
Shares issued with exercise of warrants, shares				2,993,227
Return of treasury shares				(8,320)
Net loss	(17,302)							(17,312)	(17,312)			10
Ending Balance at Jun. 30, 2021	$ 53,568			$ 273,875			$ 47,491	$ (267,860)	$ 53,506			$ 62
Ending Balance, Shares at Jun. 30, 2021	593,898,521			593,898,521

Condensed Consolidated Interi_4

Condensed Consolidated Interim Statements of Cash Flows (unaudited) $ in Thousands	6 Months Ended
	Jun. 30, 2021USD ($)	Jun. 30, 2020USD ($)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$ (17,302)	$ (8,431)
Adjustments to reconcile net loss to net cash used by operating activities
Depreciation and amortization	2,166	4,296
Equity based compensation	5,375	2,275
Change in fair value of derivative liability	2,843
Accretion of lease liability	(478)	342
Amortization of right-of-use assets	1,765	425
Accretion of lease receivable	349	(163)
Accretion of convertible debenture and interest	850	(331)
Write-off of fixed asset from terminated lease	1,210
Accretion of contingent consideration	228	24
Gain on restructuring note payable		(281)
Amortization of loan discount upon conversion of debt to equity	2,915
Deferred taxes	632
Accrued interest on notes payable	3,884	3,043
Changes in operating assets and liabilities	(170)	(2,088)
NET CASH PROVIDED BY (USED IN) CONTINUED OPERATING ACTIVITIES	4,267	(889)
Net cash provided by discontinued operation activities		7,107
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	4,267	6,218
CASH FLOWS FROM INVESTING ACTIVITIES
Notes receivable repayments	405	998
Sale of dispensary and interests in cannabis licenses	1,093
Long term deposits		2,745
Purchases of property and equipment	(12,234)	(6,639)
NET CASH PROVIDED BY (USED IN) CONTINUED INVESTING ACTIVITIES	(10,736)	(2,896)
Net cash used in discontinued investing activities		(59)
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	(10,736)	(2,955)
CASH FLOWS FROM FINANCING ACTIVITIES
Payment of contingent consideration	(1,204)	(750)
Issuance of convertible notes		8,597
Proceeds from the exercise of warrants	1,664
Proceeds from the exercise of stock options	1,314
Repayment of convertible debt		(2,810)
Repayment of notes payable	(2,674)	(3,455)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	(900)	1,582
NET INCREASE (DECREASE) IN CASH	(7,369)	4,845
CASH INCLUDED IN ASSETS HELD FOR SALE		(1,552)
CASH, BEGINNING OF PERIOD	18,932	8,141
CASH, END OF PERIOD	$ 11,563	$ 11,434

Nature of Operations

Nature of Operations	6 Months Ended
	Jun. 30, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Nature of Operations	1. NATURE OF 4Front . On July 31, 2019, 4Front Holdings LLC (“Holdings”) completed a Reverse Takeover Transaction (“RTO”) with Cannex Capital Holdings, Inc. (“Cannex”) whereby Holdings acquired Cannex, for accounting purposes, and the shareholders of Holdings became the controlling shareholders of the Company. The subordinate voting shares of the Company are listed on the Canadian Securities Exchange (“CSE”) under the ticker “FFNT” and are The Company has two primary operating segments: THC Cannabis and CBD Wellness. With regard to its THC Cannabis segment, as of June 30, 2021, the Company operates five dispensaries in Massachusetts, Illinois, and Michigan, primarily under the “MISSION” brand name. As of June 30, 2021, the Company operates two production facilities in Massachusetts and Illinois and produces the majority of products that are sold at its own Massachusetts and Illinois dispensaries. Also, as part of its THC Cannabis segment, the Company sells equipment, supplies and intellectual property to cannabis producers in the state of Washington. The Company’s CBD Wellness segment is focused upon its ownership and operation of its wholly-owned subsidiary, Pure Ratios Holdings, Inc. (“Pure Ratios”), a CBD-focused wellness company in California, that sells non-THC products throughout the United States. Management is currently continuing to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and results of its operations the specific impact is not readily determinable as of the date of these consolidated financial statements. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. See “Recent Developments – COVID-19”. The corporate office address of the Company is 5060 North 40 th Our telephone number is (602) 633-3067 and our website is accessible at https://4frontventures.com.

Basis of Presentation

Basis of Presentation	6 Months Ended
	Jun. 30, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Basis of Presentation	2. BASIS The accompanying unaudited condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) applicable to interim financial information and with the rules and regulations of the United States Securities and Exchange Commission. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed, or omitted, pursuant to such rules and regulations. In the opinion of management, the unaudited interim financial statements include all adjustments necessary for the fair presentation of the results of the interim periods presented. All adjustments are of a normal recurring nature, except as otherwise noted below. These financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended December 31, 2020, included in the Company’s Annual Report on Form 10-K, filed April 7, 2021, with the U.S. Securities and Exchange Commission and on the System for Electronic Document Analysis and Retrieval in Canada (or SEDAR). The results of operations for the interim periods are not necessarily indicative of the results of operations for any other interim period or for a full fiscal year. There have been no changes to the Company’s significant accounting policies as described in Note 2 of the Company’s 2020 Form 10-K. Principles of consolidation The accompanying condensed consolidated interim financial statements include the accounts of the Company and all entities in which the Company either has a controlling voting interest or is the primary beneficiary of a variable interest entity. All intercompany accounts and transactions have been eliminated on consolidation. The financial statements of the subsidiaries are prepared for the same reporting period as the parent company, using consistent accounting policies.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (a) Critical accounting estimates Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of the Company’s condensed consolidated interim financial statements We cannot predict what future laws and regulations might be passed that could have a material effect on our results of operations. We assess the impact of significant changes in laws and regulations on a regular basis and update the assumptions and estimates used to prepare our financial statements when we deem it necessary. (b) Recent Accounting Pronouncements Recently (i) Effective January 1, 2021, the Company adopted Accounting Standards Update ("ASU") No. 2019-12, "Income Taxes - Simplifying the Accounting for Income Taxes." This ASU is intended to simplify various aspects of accounting for income taxes by eliminating certain exceptions within Accounting Standards Codification Topic 740, "Income Taxes" and to clarify certain aspects of the current accounting guidance. Adoption of this standard did not materially impact the Company's consolidated financial position, results of operations or cash flows. Accounting Pronouncements Not Yet Adopted (i) In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470- 20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. This ASU (1) simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20, Debt: Debt with Conversion and Other Options, that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock; (2) revises the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification; and (3) revises the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares. For SEC filers, excluding smaller reporting companies, ASU 2020-06 is effective for fiscal years beginning after December 15, 2021 including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. For all other entities, ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Entities should adopt the guidance as of the beginning of the fiscal year of adoption and cannot adopt the guidance in an interim reporting period. The Company is currently evaluating the impact that ASU 2020-06 may have on its consolidated financial statements and related disclosures. Management does not believe that any other recently issued, but not yet effective, accounting standard if currently adopted would have a material effect on the accompanying consolidated financial statements.

Inventory

Inventory	6 Months Ended
	Jun. 30, 2021
Inventory Disclosure [Abstract]
Inventory	4 . INVENTORY Inventory consists of the following items: June 30, 2021 December 31, 2020 Raw materials – unharvested cannabis $ 7,010 $ 4,907 Work in process – flower and extract 9,656 9,454 Finished goods – cultivation supplies 117 886 Finished goods – packaged products 5,817 2,790 Total inventory $ 22,600 $ 18,037

Intangible Assets and Goodwill

Intangible Assets and Goodwill	6 Months Ended
	Jun. 30, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	5 . INTANGIBLE ASSETS AND GOODWILL (a) Intangible Intangible assets are recorded at cost less accumulated amortization and impairment losses. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Amortization of definite life intangibles is recognized on a straight-line basis over their estimated useful lives. The estimated useful lives, residual values, and amortization methods are reviewed at each year end, and any changes in estimates are accounted for prospectively. Licenses Customer Relationships Non- Competition Agreements Trademarks Know- How Total Balance, December 31, 2019 $ 20,146 $ 2,247 $ 137 $ 3,725 $ 8,892 $ 35,147 Amortization expense — (579 ) (94 ) (377 ) (1,959 ) (3,009 ) Impairment — — — (3,348 ) — (3,348 ) Balance, December 31, 2020 $ 20,146 $ 1,668 $ 43 $ — $ 6,933 $ 28,790 Amortization expense — (290 ) (25 ) — (951 ) (1,266 ) Balance, June 30, 2021 $ 20,146 $ 1,378 $ 18 $ — $ 5,982 $ 27,524 (b) Goodwill A summary Balance, December 31, 2019 $ 40,283 Disposal of PHX/Greens Goddess (Note 19) (5,134 ) Tax adjustment to Goodwill from Cannex acquisition 1,406 Impairment (13,400 ) Balance, December 31, 2020 $ 23,155 Balance, June 30, 2021 $ 23,155 (c) Impairment of On an annual basis, the Company assesses the Company’s reporting unit’s (“RUs”) for indicators of impairment or it is more likely than not that fair value Goodwill for impairment Year Ended December 31, 2020 Management identified negative trigger events regarding its online CBD business. Management has concluded that the overall financial performance of Pure Ratio continued to be worse than expectations, including revenue growth, EBITDA/cash flows, and future growth projections. The Pure Ratio’s business operates at a breakeven (i.e., zero) profit level and is not expected to improve in the near term. As such, management had determined that the Goodwill and remaining intangible assets associated with the Pure Ratio’s RU are impaired. As such, the remaining goodwill of $13,400 and $3,348 in trademarks were written off as of December 31, 2020.

Leases

Leases	6 Months Ended
	Jun. 30, 2021
Leases [Abstract]
Leases	6 . LEASES All real estate leases are recorded on the balance sheet. Equipment and other non-real estate leases with an initial term of twelve months or less are not recorded on the balance sheet. Balances related to operating leases are included in Right of Use (“ROU”) assets and noncurrent lease liabilities on the consolidated balance sheet. Lease agreements for some locations provide for rent escalations and renewal options. Many leases include one or more options to renew the lease at the end of the initial term. The Company considered renewals in its ROU assets and operating lease liabilities. Certain real estate leases require payment for taxes, insurance and maintenance which are considered non-lease components. The Company accounts for real estate leases and the related fixed non-lease components together as a single component. The Company determines if an arrangement is a lease at inception. The Company must consider whether the contract conveys the right to control the use of an identified asset. Certain arrangements require significant judgment to determine if an asset is specified in the contract and if the Company directs how and for what purpose the asset is used during the term of the contract. Operating lease expense for the three and six months ended June 30, 2021 and 2020 is $2,400 and $821 respectively and for the six months ended is June 30, 2021 and 2020 is $4,868 and $2,375 respectively. (a) The Company as a Lessee The following table summarizes the Company’s operating leases: Classification - Consolidated Interim Balance Sheets June 30, 2021 December 31, 2020 Assets Operating lease assets Operating lease assets $ 60,701 $ 62,466 Liabilities Current Operating Current portion of operating lease liabilities 1,127 1,909 Non Current Operating Operating lease liabilities 51,849 51,545 Total lease liabilities $ 52,976 $ 53,454 Maturities of lease liabilities for third-party operating leases as of June 30, 2021 were as follows: Third-Party Maturities of Lease Liability 2021 $ 4,384 2022 8,982 2023 9,183 2024 9,390 2025 9,551 Thereafter 127,913 Total minimum lease payments $ 169,403 The Company has right-of-use assets and lease liabilities for leased real estate for dispensaries, June 30, 2021 between (b) The Company leases a The Company owned buildings in Olympia, Washington that were leased to a third party. This lease was classified as a finance lease. On December 17, 2020, the Company sold the Olympia building and other assets as part of a sale and leaseback transaction and this lease was cancelled. The Company applied ASC 842 to a new sublease to the same third party and classified the new sublease as an operating lease. The lease receivable was sold to the purchaser of the assets as part of the sale and leaseback transaction. The following table summarizes changes in the Company’s lease receivables: June 30, 2021 December 31, 2020 Balance, beginning of the year $ 11,045 $ 33,500 Acquisitions — — Sale of assets in sale leaseback — (22,508 ) Interest 1,361 11,019 Lease payments received (1,710 ) (10,966 ) Balance, end of the period $ 10,696 $ 11,045 Less current portion (3,540 ) (3,450 ) Long term lease receivables $ 7,156 $ 7,595 Future As of June 30, 2021 2021 $ 1,740 2022 3,630 2023 1,575 2024 — 2025 — Thereafter — Total minimum lease payments $ 6,945 Effect of discounting (1,384 ) Present value of minimum lease payments 5,561 Present value of residual of leased property 5,135 Total lease receivable $ 10,696 Current portion lease receivable (3,540 ) Long term lease receivable $ 7,156

Notes Payable and Convertible N

Notes Payable and Convertible Notes	6 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
Notes Payable and Convertible Notes	7 . NOTES PAYABLE AND CONVERTIBLE NOTES The Gotham Green Partners, LLC LI Lending, LLC May 2020 Convertible Notes May 2020 Convertible Notes (Swap) Other Loans Total Balance, December 31, 2019 $ 35,607 $ 44,289 $ — $ — $ 8,093 $ 87,989 Loans advanced, net 2,810 — 5,827 — 509 9,146 Equity exchanged — — — 13,661 — 13,661 Equity component (692 ) — (3,982 ) — (1,168 ) (5,842 ) Accretion income (643 ) — — — — (643 ) Loan payments (39,855 ) (6,840 ) — — (685 ) (47,380 ) Gain on extinguishment of debt (1,218 ) — — — — (1,218 ) Converted to equity — — (145 ) (1,794 ) — (1,939 ) Accrued interest 3,991 7,913 1,155 — 182 13,241 Balance, December 31, 2020 $ — $ 45,362 $ 2,855 $ 11,867 $ 6,931 $ 67,015 Loans advanced, net — — — — 930 930 Equity component — — — — — — Loan payments — (2,317 ) — — (357 ) (2,674 ) Converted to equity — — (5,852 ) (11,867 ) — (17,719 ) Accrued interest — 3,798 2,997 — 854 7,649 Balance, June 30, 2021 $ — $ 46,843 $ — $ — $ 8,358 $ 55,201 Gotham Green Partners, LLC LI Lending, LLC May 2020 Convertible Notes May 2020 Convertible Notes (Swap) Other Loans Total Balance, December 31, 2020 $ — $ 45,362 $ 2,855 $ 11,867 $ 6,931 $ 67,015 Less current portion — — — — (5,024 ) (5,024 ) Long term portion — 45,362 2,855 11,867 1,907 61,991 Balance, June 30, 2021 $ — $ 46,843 $ — $ — $ 8,358 $ 55,201 Less current portion — — — — (6,539 ) (6,539 ) Long term portion $ — $ 46,843 $ — $ — $ 1,819 $ 48,662 Convertible Notes On May 14, 2020, the Company issued $5,827 in convertible notes to existing investors in the Company (“May 2020 Convertible Notes”). The notes pay interest of 5% per annum and have a maturity date of Feb 28, 2022. The notes can be converted into Class A Subordinate Voting Shares of the Company for $0.25 per share at any time at the option of the holder. The Company can require mandatory conversion at any time that the Company’s stock price remains above $0.50 for 45 consecutive days. During the first quarter 2021, the Company exercised the mandatory conversion feature and converted the May 2020 Convertible Note balance to subordinate voting shares. As part of issuing the convertible notes, the investors were given the right to exchange stock in the Company into separate convertible notes (swap notes) (“May 2020 Convertible Notes (Swap)”). In total 29,448,468 shares with a value of $13,661 were exchanged for $13,661 in convertible notes. These notes were effective May 28, 2020, have a maturity date of May 28, 2025, and can be converted into Class A Subordinate Voting Shares of the Company for $0.46 per share at any time at the option of the holder. The notes pay no interest if the Company’s annual revenue is greater than $15,000, and 3% annually otherwise. conversion at any time that the Company’s stock price remains above $ 0.92 for 45 consecutive days . During April 2021, the Company exercised the mandatory conversion feature and converted the May 2020 Convertible Note (Swap) balance to subordinate voting shares. Gotham Through , acquisition equity. The Company used an independent valuation company to value the notes using a 10.25% discount rate, which management determined was the rate for similar notes with no conversion feature or warrants. The notes were repaid in full in December 2020. On January 29, 2020, the Company issued convertible secured promissory notes for a total of $3,000 to entities associated with GGP. These notes were due on July 29, 2020 and accrued interest at 15% per annum with no payments due until the maturity date. LI On In April 2020, the loan was amended. In exchange for consent to allow the sale of the Pennsylvania and Maryland assets and the release of related collateral, the Company agreed to make prepayments of principal to LI Lending in the amount of $250 per month for an eight-month In December 2020, the loan was amended to allow for the release of collateral for the sale lease back transactions described in Note 6 above, which were entered into with Innovative Industrial Properties, Inc. (“IIPR”). The amendment increased both interest rates by 2.5% on the loan amounts but allowed the payments resulting from the incremental interest to be deferred until January 1, 2022. The Company elected to defer payment, and the additional 2.5% interest is accrued each month and added to the balance of the loan. The Company is still required to make interest-only payments monthly of 10.25% on the initial $33,000 and 12.25% on the final $10,000 of the loan until January 1, 2022 when the interest rates of 12.75% for the initial $33,000 and 14.75% for the final $10,000 will take effect for the remaining term. The loan matures on May 10, 2024. An exit fee of 20% of the principal balance will be due as principal is repaid. Monthly interest-only payments are required, and the Company has paid all interest due as of June 30, 2021. Other Outstanding as of June 30, 2021 were other payables totaling $8,358 which include notes issued Subsidiary Terms June 30, 2021 December 31, 2020 Healthy Pharms Inc. Unsecured convertible note at $0.50 per share, due November 18, 2021 at 12% per annum $ 2,420 $ 1,652 Healthy Pharms Inc. Unsecured promissory note, due November 18, 2021 2,905 2,823 Om of Medicine, LLC Membership interest purchase agreement contingent payment due December 1, 2021 at 10% per annum 485 — Arkansas Entities Unsecured promissory note, monthly interest payments at 14% per annum 1,730 1,730 Equipment Loans Secured by equipment, monthly payments beginning in 2021 at 15% per annum 645 512 Other Various 173 214 Total Notes Payable and Convertible Notes $ 8,358 $ 6,931 Future June 30, 2021 2021 $ 5,498 2022 1,730 2023 — 2024 53,180 2025 — Thereafter — Total minimum payments 60,408 Effect of discounting (5,207 ) Present value of minimum payments 55,201 Current portion (6,539 ) Long-term portion $ 48,662

Share Capital and Equity

Share Capital and Equity	6 Months Ended
	Jun. 30, 2021
Stockholders Equity Note [Abstract]
Share Capital and Equity	8 . SHARE The Company has authorized an unlimited number of Class A Subordinate Voting Shares (“SVS”), and Class C Multiple Voting Shares (“MVS”), all with no par value. All share classes are included within share capital in the consolidated statements of shareholder’s equity on an as converted basis. Each share class is entitled to notice of and to attend at any meeting of the shareholders, except a meeting of which only holders of another particular class of shares will have the right to vote. All share classes are entitled to receive dividends as, and when declared by the Company, on an as-converted basis, and no dividends will be declared by the Company on any individual class unless the Company simultaneously declares or pays dividends on all share classes. No subdivision or consolidation of any share class shall be made without simultaneously subdividing or consolidating all share classes in the same manner. Class Holders Class C Multiple Voting Shares Holders Series Shares outstanding as of June 30, 2021 As converted to SVS Shares Class A – Subordinate Voting Shares 592,622,313 592,622,313 Class C – Multiple Voting Shares 1,276,208 1,276,208 593,898,521 593,898,521 On November 23, 2020, the Company closed a bought deal prospectus offering of 24,644,500 Units at a price of C$ 0.70 per Unit. Each Unit is comprised of one SVS of the Company and one-half Because of the Canadian dollar denominated exercise price, these warrants do not qualify to be classified within equity and are therefore classified as derivative liabilities at fair value through profit or loss “FVTPL”. On November 23, 2020, the warrants were valued using the Black Scholes option pricing model at $4,229 using the following assumptions: Share Price: C$0.94; Exercise Price: C$0.90; Expected Life: 2 years; Annualized Volatility: 87.73%; Dividend yield: 0%; Discount Rate: 0.16%; C$ Exchange Rate: 1.31. On June 30, 2021, the warrants were revalued using the Black Scholes option pricing model, using the following assumptions: Share Price: C$1.56; Expected Life: 1.40 years, Annualized Volatility: 86.20%; Dividend yield: 0%; Discount Rate: 0.07%; C$ Exchange Rate: 1.24. The increase in the value of the derivative liability is reflected in the statement of comprehensive loss as a $2,843 loss on the change in fair value of the derivative liability for the six months ended June 30, 2021.

Warrants

Warrants	6 Months Ended
	Jun. 30, 2021
Warrants And Rights Note Disclosure [Abstract]
Warrants	9 . WARRANTS As June 30, 2021 , there were share purchase warrants outstanding to purchase up to 39,779,765 SVS : Series Number of warrants Weighted average exercise price Balance, December 31, 2020 42,772,992 $ 0.90 Issued — — Exercised (2,993,227 ) 0.68 Balance, June 30, 2021 39,779,765 $ 0.92 As Warrants Outstanding Exercise Price Expiry Date 7,000,000 $ 1.00 November 21, 2021 4,511,278 $ 1.33 November 21, 2021 2,010,050 $ 1.99 November 21, 2021 10,469,350 $ C0.90 November 23, 2022 298,085 $ C0.70 November 23, 2022 12,135,922 $ 0.82 December 17, 2022 2,230,080 $ 0.67 January 29, 2023 625,000 $ C0.80 October 6, 2024 500,000 $ C0.80 October 6, 2025 39,779,765

Share-Based Compensation

Share-Based Compensation	6 Months Ended
	Jun. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Share-Based Compensation	1 0 . SHARE-BASED The Company grants stock options under the Company’s Amended and Restated Stock Option Plan. Under the terms of the plan, the maximum number of stock options which may be granted are a total of ten percent of the number of shares outstanding assuming conversion of all shares to SVS. The exercise price for stock options issued under the plan will be set by the compensation committee of the board of directors but will not be less than 100% of the fair market value of the Company’s shares on the grant date. Stock options have a maximum term of 5 years from the date of grant. Stock options vest at the discretion of the Board. As of June 30, 2021, the Company had the following options outstanding and exercisable on an as-converted Grant Date Strike Price in C$ Options Outstanding Exercisable Options Life Remaining (years) July 31, 2019 1.00 7,983,332 7,983,332 1.45 July 31, 2019 1.00 1,166,667 1,166,667 2.27 July 31, 2019 1.50 516,666 516,666 2.95 July 31, 2019 1.50 800,000 333,334 2.97 July 31, 2019 0.10 6,245,840 6,245,840 3.21 August 22, 2019 0.80 6,150,000 1,881,450 3.15 August 22, 2019 1.00 5,850,104 2,772,913 3.15 November 1, 2019 0.80 1,200,000 400,000 3.34 February 3, 2020 0.80 425,000 158,333 3.60 June 8, 2020 0.80 25,000 8,333 3.60 July 31, 2020 0.80 1,200,000 1,500,000 4.09 September 15, 2020 0.86 7,978,400 3,689,200 4.21 October 2, 2020 0.77 3,000,000 1,500,000 4.26 November 24, 2020 0.94 1,775,000 1,775,000 4.41 December 2, 2020 1.11 2,900,000 1,450,000 4.43 December 21, 2020 1.06 1,200,000 — 4.48 March 18, 2021 1.63 6,850,000 — 4.72 April 2, 2021 1.36 200,000 — 4.72 April 21, 2021 1.58 175,000 — 4.72 June 23, 2021 1.56 450,000 — 4.98 June 28, 2021 1.57 200,000 — 5.00 56,291,009 31,381,068 3.49 Stock option activity is summarized as follows: Number of Weighted Average Weighted Average Options Price CAD$ Years Balance December 31, 2019 40,028,465 0.86 4.12 Granted 19,190,960 0.90 — Exercised — — — Forfeited (8,792,360 ) 1.04 — Balance December 31, 2020 50,427,065 0.84 3.72 Granted 7,875,000 1.63 4.97 Exercised (2,011,056 ) 0.93 4.97 Balance June 30, 2021 56,291,009 0.94 3.49 The Company recognized share-based compensation expense of $2,979 and $684 during the second quarters of 2021 and 2020 and $5,375 and $2,276 during the respective year-to-date periods In determining the amount of equity-based compensation during the period, the Company used the Black-Scholes option pricing model to establish fair value of options granted during the period with the following key assumption: Risk-Free Interest Rate 0.87% to 0.92% Expected Life of Options (years) 5.00 Expected Annualized Volatility 86.2% to 93.53% Expected Dividend Yield nil

Related Parties

Related Parties	6 Months Ended
	Jun. 30, 2021
Related Party Transactions [Abstract]
Related Parties	11 . RELATED Related An officer and director of the Company, and a director of the Company serve as principals of LI Lending LLC, which extended the Company a real estate improvement/development loan of $50,000 of which $46,843 was outstanding as of June 30, 2021. An officer of the Company holds an interest in an online marketing company serving the online CBD market which provides online marketing services for Pure Ratios. Pure Ratios paid $313 (2020 – $2,334) for the six months ended June 30, 2021 to this vendor for management fees, pass through marketing costs and customer service. During 2020, the Company considered 7Point Holdings LLC (“7 Point”) a related party due to a common executive. However, as a result of his departure, 7Point was no longer considered a related party as of December 31, 2020. 7Point and the Company are parties to a commercial sublease expiring May 31, 2023 with one five-year

Contingencies

Contingencies	6 Months Ended
	Jun. 30, 2021
Commitments And Contingencies Disclosure [Abstract]
Contingencies	1 2 . CONTINGENCIES (a) Cannabis Cannabis is still considered a Schedule 1 substance under the Controlled Substance Act. to (b) Contingent consideration payable As part of the acquisition of Om of Medicine, LLC the Company is subject to contingent consideration payable to the original sellers. The fair value Om of Medicine Balance, December 31, 2020 $ 5,496 Additions — Accretion 228 Payments (1,201 ) Notes issued (485 ) Shares issued (722 ) Balance, June 30, 2021 $ 3,316 The contingent consideration payable is measured at fair value based on unobservable inputs and OM of Medicine : The contingent consideration payable is determined as the amount in excess of gross sales of $3,400 (for fiscal 2020 and 2021) to a maximum payable of $6,000. (c) Legal From f business. Such disputes, taken in the re also no proceedings in which Company’s interest.

Financial Instruments and Finan

Financial Instruments and Financial Risk Management	6 Months Ended
	Jun. 30, 2021
Investments All Other Investments [Abstract]
Financial Instruments and Financial Risk Management	1 3. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT The Company’s financial instruments consist of cash, accounts receivable, other receivables, notes Financial instruments recorded at fair value are classified using a fair value hierarchy that reflects the Level 1 quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices); and Level 3 The fair value of the Company’s cash, accounts receivable, other receivables, accounts payable and accrued expenses approximate the carrying value due to their short-term nature. The Company’s notes receivable, convertible notes payable, and notes payable approximate fair value due to the instruments bearing market rate of interest. There six months ended June 30, 2021 December 31, 2020 (a) The (b) Credit The risk exposure is limited to the carrying amounts at the statement of financial position date. The risk to cash deposits is mitigated by holding these instruments with regulated financial institutions. Lease receivables, notes receivables and other receivables credit risk arises from the possibility that principal and interest due may become uncollectible. The Company mitigates this risk by managing and monitoring the underlying business relationships. The Company maintains cash with federally insured financial institutions. As of June 30, 2021 and December 31, 2020, the Company exceeded federally insured limits by approximately $5,000 and $5,000 respectively. The Company has historically not experienced any losses in such accounts. As of June 30, 2021, the Company held approximately $1,121 in Canadian bank accounts that are denominated in C$. As of June 30, 2021, the maximum credit exposure related to the carrying amounts of accounts receivable, notes receivable and lease receivables was $12,431. (c) Liquidity risk is the risk that the Company will not be able to meet its financial obligations associated with financial liabilities. The Company manages liquidity risk through the management of its capital structure. The Company’s approach to managing liquidity is to raise sufficient capital to settle obligations and liabilities when due. (d) Interest rate risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company’s secured convertible notes with GGP (Note 7) had variable interest rates and were paid in full in December 2020. (e) The Company is exposed to exchange rate fluctuations between United States and Canadian dollars. The Company’s share price is denominated in Canadian dollars. If the Canadian dollar declines against the United States dollar, the United States dollar amounts available to fund the Company through the exercise of stock options or warrants will be less. The Company also has bank accounts with balances in Canadian dollars. The value of these bank balances if converted to U.S. dollars will fluctuate. While the Company maintains a head office in Canada where it incurs expenses primarily denominated in Canadian dollars, such expenses are a small portion of overall expenses incurred by the Company. The Company does not have a practice of trading derivatives and does not engage in “natural hedging” for funds held in Canada. (f) Price risk is the risk of variability in fair value due to movements in equity or market prices. The Company is subject to risk of prices to its products due to competitive or regulatory pressures.

Segment Information

Segment Information	6 Months Ended
	Jun. 30, 2021
Segment Reporting [Abstract]
Segment Information	1 4 . SEGMENT Operating segments are components of the Company that combine similar business activities, with Company’s board and management. June 30, 2021 • THC Cannabis – Production and cultivation of THC cannabis, manufacturing, and distribution of cannabis products to own dispensaries and third-party retail customers, ancillary services supporting wholesale operations, and retail sales direct to end consumers • CBD Wellness – Pure Ratios which encompasses the production and sale of CBD products to third-party customers All June 30, 2021 June 30, 2020 Net Revenues THC Cannabis $ 48,544 $ 21,894 CBD Wellness 1,547 3,459 Corporate — — Total Net Revenues $ 50,091 $ 25,353 Depreciation and Amortization THC Cannabis $ 1,589 $ 1,847 CBD Wellness 16 41 Corporate 30 — Total Depreciation and Amortization $ 1,635 $ 1,888 June 30, 2021 December 31, 2020 Assets THC Cannabis $ 201,091 $ 186,899 CBD Wellness 1,815 2,198 Corporate 5,858 15,659 Total Assets $ 208,764 $ 204,756 Goodwill assigned to the THC Cannabis segment as of June 30, 2021 and December 31, 2020 was $23,155. Intangible assets, net assigned to the THC Cannabis segment as of June 30, 2021 and December 31, 2020 was $27,524 and $28,790, respectively. Goodwill and Intangible Assets assigned to the CBD Wellness segment as of June 30, 2021 and December 31, 2020 were $nil.

Supplementary Cash Flow Informa

Supplementary Cash Flow Information	6 Months Ended
	Jun. 30, 2021
Supplemental Cash Flow Information [Abstract]
Supplementary Cash Flow Information	15. SUPPLEMENTARY CASH FLOW INFORMATION Changes Changes in operating assets and liabilities 2021 2020 Accounts receivable $ (815 ) $ 33 Deposits (70 ) — Inventory (4,563 ) (2,616 ) Prepaid expenses 50 360 Accounts payable and other liabilities 65 (2,501 ) Taxes payable 5,163 2,636 $ (170 ) $ (2,088 ) • Cash paid for interest in for six months ended June 30, 2021 and 2020 was $1,662 and $3,765, respectively. • Cash paid for income taxes for the six months ended June 30, 2021 and 2020 was $224 and $nil, respectively.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	1 6 . INCOME TAXES The following table summarizes the Company’s income tax expense and effective tax rates for the six months ended June 30, 2021 and 2020: Six Months Ended June 30, 2021 2020 Net loss before income taxes $ (11,298 ) $ (5,096 ) Income tax expense $ (6,004 ) $ (3,335 ) Effective tax rate (53.14 )% (65.44 )% The Company has computed its provision for income taxes under the discrete method which treats the year-to-date period as if it were the annual period and determines the income tax expense or benefit on that basis. The discrete method is applied when application of the estimated annual effective tax rate is impractical because it is not possible to reliably estimate the annual effective tax rate. The Company believes the use of this discrete method is more appropriate than the annual effective tax rate method due to the early growth stage of the business. At this time, there is a high degree of uncertainty in estimating the Company’s annual pre-tax income and significant non-deductible expenses so the Company cannot reliably estimate the annual effective tax rate. Internal Revenue Code (“IRC”) Section 280E denies, at the U.S. federal level, deductions, and credits attributable to a trade or business trafficking in controlled substances. Because the Company is subject to IRC Section 280E, the Company has computed its U.S. tax based on gross receipts less cost of goods sold. The tax provisions for the six months ended June 30, 2021 and 2020, have been prepared based on the assumption that cost of goods sold is a valid expense for income tax purposes. The effective tax rate for the six months ended June 30, 2021 varies widely from the six months ended June 30, 2020, primarily due to the increase in non-deductible expenses as a proportion of total expenses in the current year. The Company incurs expenses that are not deductible due to IRC Section 280E limitations which results in significant income tax expense. The federal statute of limitation remains open for the 2017 tax year to the present. The state income tax returns generally remain open for the 2016 tax year through the present. Net operating losses arising prior to these years are also open to examination if and when utilized.

Disposals and Discontinued Oper

Disposals and Discontinued Operations	6 Months Ended
	Jun. 30, 2021
Discontinued Operations And Disposal Groups [Abstract]
Disposals and Discontinued Operations	1 7 . DISPOSALS On January 21, 2020, the Company sold two management companies that controlled two Arkansas On March 20, 2020, the Company completed the divestiture of a sale to a third party for $6,000 in cash. The Company paid a $348 fee to a lender in exchange for allowing the Company to sell the dispensary net income from discontinued operations Between April 1, 2020 and September 30, 2020, the Company completed the sale of dispensaries in Pennsylvania, Maryland, and Arkansas, and of management companies that control three additional dispensaries in Maryland. Revenue and expenses from these operations have been eliminated from the loss from the Company’s continuing operations for the three months ended March 31, 2020 and are shown as part of net income from discontinued operations in the condensed consolidated interim statements of operations and comprehensive loss. The entities that were sold during the six months ended June 30, 2021 and 2020 were part of the THC Cannabis segment (Note 14). operations that is shown as a single line item for the three and six months ended June 30, 2021 and 2020: Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 REVENUE $ — $ 4,423 $ — $ 9,421 Cost of goods sold — (2,791 ) — (6,107 ) Gross profit — 1,632 — 3,314 OPERATING EXPENSES Selling and marketing expenses — 1,270 — 3,007 Depreciation and amortization — — — 353 Gain on sale of subidiary — (9,559 ) — (11,211 ) Total operating (income) expenses — (8,289 ) — (7,851 ) Income from operations — 9,921 — 11,165 Interest expense — (42 ) — (41 ) Net income before income taxes — 9,879 — 11,124 Income tax expense — (39 ) — (412 ) Net income after income tax expense $ — $ 9,840 $ — $ 10,712 Cash flows generated by the discontinued operations are reported as a single line item in each section of the condensed consolidated interim statements of cash flows and are summarized as follows: Six Months Ended June 30, 2021 2020 Net cash used in operating activities $ — $ 7,107 Net cash used in investing activities — (59 ) Net cash provided by financing activities — — Cash flows from discontinued operations $ — $ 7,048

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	18 . SUBSEQUENT (a) Illinois Development Project The Company announced on August 5, 2021 the first closing of a multiphase expansion project to build an up to 558,000 sq. ft. cultivation and production facility (the “Facility”) in the Village of Matteson, Illinois, located outside of Chicago. The Company plans to use the Facility to produce the Company's more than 20 in-house brands and 200 products, which will be offered to Illinois customers at an accessible price point at its Mission Dispensaries and partner dispensaries across Illinois. (b) Approval for Adult-Use Cannabis Sales On July 15, 2021, the Company received final approval from the Massachusetts Cannabis Control Commission to open the Company’s third adult-use retail dispensary in Massachusetts. Located at 1024 Commonwealth Avenue, Boston, MA, the dispensary will hold its grand opening on August 21, 2021.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Principles of consolidation	Principles of consolidation The accompanying condensed consolidated interim financial statements include the accounts of the Company and all entities in which the Company either has a controlling voting interest or is the primary beneficiary of a variable interest entity. All intercompany accounts and transactions have been eliminated on consolidation. The financial statements of the subsidiaries are prepared for the same reporting period as the parent company, using consistent accounting policies.
Critical accounting estimates and judgements	(a) Critical accounting estimates Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of the Company’s condensed consolidated interim financial statements We cannot predict what future laws and regulations might be passed that could have a material effect on our results of operations. We assess the impact of significant changes in laws and regulations on a regular basis and update the assumptions and estimates used to prepare our financial statements when we deem it necessary.
Recent Accounting Pronouncements	(b) Recent Accounting Pronouncements Recently (i) Effective January 1, 2021, the Company adopted Accounting Standards Update ("ASU") No. 2019-12, "Income Taxes - Simplifying the Accounting for Income Taxes." This ASU is intended to simplify various aspects of accounting for income taxes by eliminating certain exceptions within Accounting Standards Codification Topic 740, "Income Taxes" and to clarify certain aspects of the current accounting guidance. Adoption of this standard did not materially impact the Company's consolidated financial position, results of operations or cash flows. Accounting Pronouncements Not Yet Adopted (i) In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470- 20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. This ASU (1) simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20, Debt: Debt with Conversion and Other Options, that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock; (2) revises the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification; and (3) revises the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares. For SEC filers, excluding smaller reporting companies, ASU 2020-06 is effective for fiscal years beginning after December 15, 2021 including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. For all other entities, ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Entities should adopt the guidance as of the beginning of the fiscal year of adoption and cannot adopt the guidance in an interim reporting period. The Company is currently evaluating the impact that ASU 2020-06 may have on its consolidated financial statements and related disclosures. Management does not believe that any other recently issued, but not yet effective, accounting standard if currently adopted would have a material effect on the accompanying consolidated financial statements.

Inventory (Tables)

Inventory (Tables)	6 Months Ended
	Jun. 30, 2021
Inventory Disclosure [Abstract]
Summary of Inventory	Inventory consists of the following items: June 30, 2021 December 31, 2020 Raw materials – unharvested cannabis $ 7,010 $ 4,907 Work in process – flower and extract 9,656 9,454 Finished goods – cultivation supplies 117 886 Finished goods – packaged products 5,817 2,790 Total inventory $ 22,600 $ 18,037

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	6 Months Ended
	Jun. 30, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
Summary of Intangible Assets	Licenses Customer Relationships Non- Competition Agreements Trademarks Know- How Total Balance, December 31, 2019 $ 20,146 $ 2,247 $ 137 $ 3,725 $ 8,892 $ 35,147 Amortization expense — (579 ) (94 ) (377 ) (1,959 ) (3,009 ) Impairment — — — (3,348 ) — (3,348 ) Balance, December 31, 2020 $ 20,146 $ 1,668 $ 43 $ — $ 6,933 $ 28,790 Amortization expense — (290 ) (25 ) — (951 ) (1,266 ) Balance, June 30, 2021 $ 20,146 $ 1,378 $ 18 $ — $ 5,982 $ 27,524
Summary of Goodwill	A summary Balance, December 31, 2019 $ 40,283 Disposal of PHX/Greens Goddess (Note 19) (5,134 ) Tax adjustment to Goodwill from Cannex acquisition 1,406 Impairment (13,400 ) Balance, December 31, 2020 $ 23,155 Balance, June 30, 2021 $ 23,155

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jun. 30, 2021
Leases [Abstract]
Summary of Company's Operating Leases	The following table summarizes the Company’s operating leases: Classification - Consolidated Interim Balance Sheets June 30, 2021 December 31, 2020 Assets Operating lease assets Operating lease assets $ 60,701 $ 62,466 Liabilities Current Operating Current portion of operating lease liabilities 1,127 1,909 Non Current Operating Operating lease liabilities 51,849 51,545 Total lease liabilities $ 52,976 $ 53,454
Summary of Maturities Lease Liabilities For Third-Party Operating Leases	Maturities of lease liabilities for third-party operating leases as of June 30, 2021 were as follows: Third-Party Maturities of Lease Liability 2021 $ 4,384 2022 8,982 2023 9,183 2024 9,390 2025 9,551 Thereafter 127,913 Total minimum lease payments $ 169,403
Summary of Changes in Lease Receivables	June 30, 2021 December 31, 2020 Balance, beginning of the year $ 11,045 $ 33,500 Acquisitions — — Sale of assets in sale leaseback — (22,508 ) Interest 1,361 11,019 Lease payments received (1,710 ) (10,966 ) Balance, end of the period $ 10,696 $ 11,045 Less current portion (3,540 ) (3,450 ) Long term lease receivables $ 7,156 $ 7,595
Summary of Future Minimum Lease Payments (Principal and Interest) on Leases (Lessor)	Future As of June 30, 2021 2021 $ 1,740 2022 3,630 2023 1,575 2024 — 2025 — Thereafter — Total minimum lease payments $ 6,945 Effect of discounting (1,384 ) Present value of minimum lease payments 5,561 Present value of residual of leased property 5,135 Total lease receivable $ 10,696 Current portion lease receivable (3,540 ) Long term lease receivable $ 7,156

Notes Payable and Convertible_2

Notes Payable and Convertible Notes (Tables)	6 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
Summary of Notes Payable and Convertible Notes	The Gotham Green Partners, LLC LI Lending, LLC May 2020 Convertible Notes May 2020 Convertible Notes (Swap) Other Loans Total Balance, December 31, 2019 $ 35,607 $ 44,289 $ — $ — $ 8,093 $ 87,989 Loans advanced, net 2,810 — 5,827 — 509 9,146 Equity exchanged — — — 13,661 — 13,661 Equity component (692 ) — (3,982 ) — (1,168 ) (5,842 ) Accretion income (643 ) — — — — (643 ) Loan payments (39,855 ) (6,840 ) — — (685 ) (47,380 ) Gain on extinguishment of debt (1,218 ) — — — — (1,218 ) Converted to equity — — (145 ) (1,794 ) — (1,939 ) Accrued interest 3,991 7,913 1,155 — 182 13,241 Balance, December 31, 2020 $ — $ 45,362 $ 2,855 $ 11,867 $ 6,931 $ 67,015 Loans advanced, net — — — — 930 930 Equity component — — — — — — Loan payments — (2,317 ) — — (357 ) (2,674 ) Converted to equity — — (5,852 ) (11,867 ) — (17,719 ) Accrued interest — 3,798 2,997 — 854 7,649 Balance, June 30, 2021 $ — $ 46,843 $ — $ — $ 8,358 $ 55,201 Gotham Green Partners, LLC LI Lending, LLC May 2020 Convertible Notes May 2020 Convertible Notes (Swap) Other Loans Total Balance, December 31, 2020 $ — $ 45,362 $ 2,855 $ 11,867 $ 6,931 $ 67,015 Less current portion — — — — (5,024 ) (5,024 ) Long term portion — 45,362 2,855 11,867 1,907 61,991 Balance, June 30, 2021 $ — $ 46,843 $ — $ — $ 8,358 $ 55,201 Less current portion — — — — (6,539 ) (6,539 ) Long term portion $ — $ 46,843 $ — $ — $ 1,819 $ 48,662
Summary of Convertible Debt	Outstanding as of June 30, 2021 were other payables totaling $8,358 which include notes issued Subsidiary Terms June 30, 2021 December 31, 2020 Healthy Pharms Inc. Unsecured convertible note at $0.50 per share, due November 18, 2021 at 12% per annum $ 2,420 $ 1,652 Healthy Pharms Inc. Unsecured promissory note, due November 18, 2021 2,905 2,823 Om of Medicine, LLC Membership interest purchase agreement contingent payment due December 1, 2021 at 10% per annum 485 — Arkansas Entities Unsecured promissory note, monthly interest payments at 14% per annum 1,730 1,730 Equipment Loans Secured by equipment, monthly payments beginning in 2021 at 15% per annum 645 512 Other Various 173 214 Total Notes Payable and Convertible Notes $ 8,358 $ 6,931
Summary of Future Minimum Payments of Notes and Convertible Notes	Future June 30, 2021 2021 $ 5,498 2022 1,730 2023 — 2024 53,180 2025 — Thereafter — Total minimum payments 60,408 Effect of discounting (5,207 ) Present value of minimum payments 55,201 Current portion (6,539 ) Long-term portion $ 48,662

Share Capital and Equity (Table

Share Capital and Equity (Tables)	6 Months Ended
	Jun. 30, 2021
Stockholders Equity Note [Abstract]
Summary of Share Capital and Equity	Series Shares outstanding as of June 30, 2021 As converted to SVS Shares Class A – Subordinate Voting Shares 592,622,313 592,622,313 Class C – Multiple Voting Shares 1,276,208 1,276,208 593,898,521 593,898,521

Warrants (Tables)

Warrants (Tables)	6 Months Ended
	Jun. 30, 2021
Warrants And Rights Note Disclosure [Abstract]
Summary of Warrants Outstanding to Purchase Shares	As June 30, 2021 , there were share purchase warrants outstanding to purchase up to 39,779,765 SVS : Series Number of warrants Weighted average exercise price Balance, December 31, 2020 42,772,992 $ 0.90 Issued — — Exercised (2,993,227 ) 0.68 Balance, June 30, 2021 39,779,765 $ 0.92
Summary of Warrants Outstanding And Exercisable	As Warrants Outstanding Exercise Price Expiry Date 7,000,000 $ 1.00 November 21, 2021 4,511,278 $ 1.33 November 21, 2021 2,010,050 $ 1.99 November 21, 2021 10,469,350 $ C0.90 November 23, 2022 298,085 $ C0.70 November 23, 2022 12,135,922 $ 0.82 December 17, 2022 2,230,080 $ 0.67 January 29, 2023 625,000 $ C0.80 October 6, 2024 500,000 $ C0.80 October 6, 2025 39,779,765

Share-Based Compensation (Table

Share-Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2021
Summary of Options Outstanding and Exercisable on an As-Converted Basis	As of June 30, 2021, the Company had the following options outstanding and exercisable on an as-converted Grant Date Strike Price in C$ Options Outstanding Exercisable Options Life Remaining (years) July 31, 2019 1.00 7,983,332 7,983,332 1.45 July 31, 2019 1.00 1,166,667 1,166,667 2.27 July 31, 2019 1.50 516,666 516,666 2.95 July 31, 2019 1.50 800,000 333,334 2.97 July 31, 2019 0.10 6,245,840 6,245,840 3.21 August 22, 2019 0.80 6,150,000 1,881,450 3.15 August 22, 2019 1.00 5,850,104 2,772,913 3.15 November 1, 2019 0.80 1,200,000 400,000 3.34 February 3, 2020 0.80 425,000 158,333 3.60 June 8, 2020 0.80 25,000 8,333 3.60 July 31, 2020 0.80 1,200,000 1,500,000 4.09 September 15, 2020 0.86 7,978,400 3,689,200 4.21 October 2, 2020 0.77 3,000,000 1,500,000 4.26 November 24, 2020 0.94 1,775,000 1,775,000 4.41 December 2, 2020 1.11 2,900,000 1,450,000 4.43 December 21, 2020 1.06 1,200,000 — 4.48 March 18, 2021 1.63 6,850,000 — 4.72 April 2, 2021 1.36 200,000 — 4.72 April 21, 2021 1.58 175,000 — 4.72 June 23, 2021 1.56 450,000 — 4.98 June 28, 2021 1.57 200,000 — 5.00 56,291,009 31,381,068 3.49
Summary of Stock Option Activity	Stock option activity is summarized as follows: Number of Weighted Average Weighted Average Options Price CAD$ Years Balance December 31, 2019 40,028,465 0.86 4.12 Granted 19,190,960 0.90 — Exercised — — — Forfeited (8,792,360 ) 1.04 — Balance December 31, 2020 50,427,065 0.84 3.72 Granted 7,875,000 1.63 4.97 Exercised (2,011,056 ) 0.93 4.97 Balance June 30, 2021 56,291,009 0.94 3.49
Equity Based Compensation Options | 4Front Holdings LLC
Summary of Stock Options Values using Black-Scholes Model with Key Assumptions	In determining the amount of equity-based compensation during the period, the Company used the Black-Scholes option pricing model to establish fair value of options granted during the period with the following key assumption: Risk-Free Interest Rate 0.87% to 0.92% Expected Life of Options (years) 5.00 Expected Annualized Volatility 86.2% to 93.53% Expected Dividend Yield nil

Contingencies (Tables)

Contingencies (Tables)	6 Months Ended
	Jun. 30, 2021
Commitments And Contingencies Disclosure [Abstract]
Schedule of Fair Value of Contingent Consideration	The fair value Om of Medicine Balance, December 31, 2020 $ 5,496 Additions — Accretion 228 Payments (1,201 ) Notes issued (485 ) Shares issued (722 ) Balance, June 30, 2021 $ 3,316

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Jun. 30, 2021
Segment Reporting [Abstract]
Summary of Revenue By Type	June 30, 2021 June 30, 2020 Net Revenues THC Cannabis $ 48,544 $ 21,894 CBD Wellness 1,547 3,459 Corporate — — Total Net Revenues $ 50,091 $ 25,353 Depreciation and Amortization THC Cannabis $ 1,589 $ 1,847 CBD Wellness 16 41 Corporate 30 — Total Depreciation and Amortization $ 1,635 $ 1,888 June 30, 2021 December 31, 2020 Assets THC Cannabis $ 201,091 $ 186,899 CBD Wellness 1,815 2,198 Corporate 5,858 15,659 Total Assets $ 208,764 $ 204,756

Supplementary Cash Flow Infor_2

Supplementary Cash Flow Information (Tables)	6 Months Ended
	Jun. 30, 2021
Supplemental Cash Flow Information [Abstract]
Summary of Changes in Non-Cash Working Capital	Changes Changes in operating assets and liabilities 2021 2020 Accounts receivable $ (815 ) $ 33 Deposits (70 ) — Inventory (4,563 ) (2,616 ) Prepaid expenses 50 360 Accounts payable and other liabilities 65 (2,501 ) Taxes payable 5,163 2,636 $ (170 ) $ (2,088 )

Income Taxes (Tables)

Income Taxes (Tables)	6 Months Ended
	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Summary of Income Tax Expense and Effective Tax Rates	The following table summarizes the Company’s income tax expense and effective tax rates for the six months ended June 30, 2021 and 2020: Six Months Ended June 30, 2021 2020 Net loss before income taxes $ (11,298 ) $ (5,096 ) Income tax expense $ (6,004 ) $ (3,335 ) Effective tax rate (53.14 )% (65.44 )%

Disposals and Discontinued Op_2

Disposals and Discontinued Operations (Tables)	6 Months Ended
	Jun. 30, 2021
Discontinued Operations And Disposal Groups [Abstract]
Summary of Net Income or Loss from Discontinued Operations	Below is a summary of the net income or loss from discontinued operations that is shown as a single line item for the three and six months ended June 30, 2021 and 2020: Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 REVENUE $ — $ 4,423 $ — $ 9,421 Cost of goods sold — (2,791 ) — (6,107 ) Gross profit — 1,632 — 3,314 OPERATING EXPENSES Selling and marketing expenses — 1,270 — 3,007 Depreciation and amortization — — — 353 Gain on sale of subidiary — (9,559 ) — (11,211 ) Total operating (income) expenses — (8,289 ) — (7,851 ) Income from operations — 9,921 — 11,165 Interest expense — (42 ) — (41 ) Net income before income taxes — 9,879 — 11,124 Income tax expense — (39 ) — (412 ) Net income after income tax expense $ — $ 9,840 $ — $ 10,712
Summary of Cash Flows Generated by Discontinued Operations	Cash flows generated by the discontinued operations are reported as a single line item in each section of the condensed consolidated interim statements of cash flows and are summarized as follows: Six Months Ended June 30, 2021 2020 Net cash used in operating activities $ — $ 7,107 Net cash used in investing activities — (59 ) Net cash provided by financing activities — — Cash flows from discontinued operations $ — $ 7,048

Nature of Operations - Addition

Nature of Operations - Additional Information (Details)	6 Months Ended
	Jun. 30, 2021SegmentDispensaryFacility
Nature Of Operations [Line Items]
Number of operating segments | Segment	2
Number of dispensaries | Dispensary	5
Massachusetts
Nature Of Operations [Line Items]
Number of production facilities	2
Illinois
Nature Of Operations [Line Items]
Number of production facilities	2

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Additional Information (Details) - Accounting Standards Update No. 2019-12	Jun. 30, 2021
Summary Of Significant Accounting Policies [Line Items]
Change In Accounting Principle Accounting Standards Update Adopted	true
Change in Accounting Principle, Accounting Standards Update, Adoption Date	Jan. 1, 2021
Change in Accounting Principle, Accounting Standards Update, Immaterial Effect	true

Inventory - Summary of Inventor

Inventory - Summary of Inventories (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Inventory [Line Items]
Total inventory	$ 22,600	$ 18,037
Unharvested Cannabis
Inventory [Line Items]
Raw materials	7,010	4,907
Flower and Extract
Inventory [Line Items]
Work in process	9,656	9,454
Cultivation Supplies
Inventory [Line Items]
Finished goods	117	886
Packaged Products
Inventory [Line Items]
Finished goods	$ 5,817	$ 2,790

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Summary of Intangible Assets (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Finite Lived Intangible Assets [Line Items]
Balance	$ 28,790	$ 35,147
Amortization expense	(1,266)	(3,009)
Impairment		(3,348)
Balance	27,524	28,790
Licenses
Finite Lived Intangible Assets [Line Items]
Balance	20,146	20,146
Balance	20,146	20,146
Customer Relationships
Finite Lived Intangible Assets [Line Items]
Balance	1,668	2,247
Amortization expense	(290)	(579)
Balance	1,378	1,668
Non-competition Agreement
Finite Lived Intangible Assets [Line Items]
Balance	43	137
Amortization expense	(25)	(94)
Balance	18	43
Trademarks
Finite Lived Intangible Assets [Line Items]
Balance		3,725
Amortization expense		(377)
Impairment		(3,348)
Know-how (trade secrets)
Finite Lived Intangible Assets [Line Items]
Balance	6,933	8,892
Amortization expense	(951)	(1,959)
Balance	$ 5,982	$ 6,933

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Summary of Goodwill (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2020USD ($)
Goodwill [Line Items]
Balance	$ 40,283
Impairment	(13,400)
Balance	23,155
PHX/Greens Goddess Acquisition
Goodwill [Line Items]
Disposal	(5,134)
Cannex Capital Holdings Inc
Goodwill [Line Items]
Tax adjustment to goodwill from acquisition	$ 1,406

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Additional Information (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2020USD ($)
Disclosure Of Intangible Assets And Goodwill [Line Items]
Goodwill impairment	$ 13,400
Intangible assets impairment written off	3,348
Trademarks
Disclosure Of Intangible Assets And Goodwill [Line Items]
Intangible assets impairment written off	3,348
Pure Ratios RU
Disclosure Of Intangible Assets And Goodwill [Line Items]
Goodwill impairment	13,400
Pure Ratios RU | Trademarks
Disclosure Of Intangible Assets And Goodwill [Line Items]
Intangible assets impairment written off	$ 3,348

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended	18 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020	Jun. 30, 2021	Dec. 31, 2019
Leases [Line Items]
Lessor, operating lease options to renew			true
Operating lease expense	$ 2,400	$ 821	$ 4,868	$ 2,375
Lease receivable	10,696		10,696		$ 11,045	$ 10,696	$ 33,500
Lease interest in real estate income			1,361		$ 11,019
Real estate income	$ 2,669	$ 2,734	5,559	$ 5,631
Lease generated in real estate income			$ 4,198
Minimum
Leases [Line Items]
Lessee incremental borrowing rate percentage						10.25%
Maximum
Leases [Line Items]
Lessee incremental borrowing rate percentage						17.00%

Leases - Summary of Company's O

Leases - Summary of Company's Operating Leases (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Assets
Operating lease assets	$ 60,701	$ 62,466
Liabilities
Current portion of operating lease liabilities	1,127	1,909
Noncurrent portion of operating lease liabilities	51,849	51,545
Total lease liabilities	$ 52,976	$ 53,454

Leases - Summary of Maturities

Leases - Summary of Maturities Lease Liabilities For Third-Party Operating Leases (Details) $ in Thousands	Jun. 30, 2021USD ($)
Leases [Abstract]
2021	$ 4,384
2022	8,982
2023	9,183
2024	9,390
2025	9,551
Thereafter	127,913
Total minimum lease payments	$ 169,403

Leases - Summary of Changes in

Leases - Summary of Changes in Lease Receivables (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Leases [Abstract]
Balance, beginning of the year	$ 11,045	$ 33,500
Sale of assets in sale leaseback		(22,508)
Interest	1,361	11,019
Lease payments received	(1,710)	(10,966)
Balance, end of the period	10,696	11,045
Less current portion	(3,540)	(3,450)
Long term lease receivables	$ 7,156	$ 7,595

Leases - Summary of Future Mini

Leases - Summary of Future Minimum Lease Payments (Principal and Interest) on Leases (Lessor) (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Leases [Abstract]
2021	$ 1,740
2022	3,630
2023	1,575
Total minimum lease payments	6,945
Effect of discounting	(1,384)
Present value of minimum lease payments	5,561
Present value of residual of leased property	5,135
Total lease receivable	10,696	$ 11,045	$ 33,500
Current portion lease receivable	(3,540)	(3,450)
Long term lease receivable	$ 7,156	$ 7,595

Notes Payable and Convertible_3

Notes Payable and Convertible Notes - Summary of Notes Payable and Convertible Notes (Details) - USD ($) $ in Thousands	May 28, 2020	May 14, 2020	Jun. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Beginning Balance			$ 67,015	$ 87,989
Loans advanced, net			930	9,146
Equity exchanged				13,661
Equity component				(5,842)
Accretion income				(643)
Loan payments			(2,674)	(47,380)
Gain on extinguishment of debt				(1,218)
Converted to equity			(17,719)	(1,939)
Accrued interest			7,649	13,241
Ending Balance			55,201	67,015	$ 87,989
Gotham Green Partners LLC
Debt Instrument [Line Items]
Beginning Balance				35,607
Loans advanced, net				2,810
Equity component				(692)	(4,874)
Accretion income				(643)
Loan payments				(39,855)
Gain on extinguishment of debt				(1,218)
Accrued interest				3,991
Ending Balance					35,607
LI Lending, LLC
Debt Instrument [Line Items]
Beginning Balance			45,362	44,289
Loan payments			(2,317)	(6,840)
Accrued interest			3,798	7,913
Ending Balance			46,843	45,362	44,289
May 2020 Convertible Notes
Debt Instrument [Line Items]
Beginning Balance			2,855
Loans advanced, net		$ 5,827		5,827
Equity component				(3,982)
Converted to equity			(5,852)	(145)
Accrued interest			2,997	1,155
Ending Balance				2,855
May 2020 Convertible Notes (Swap)
Debt Instrument [Line Items]
Beginning Balance			11,867
Equity exchanged	$ 13,661			13,661
Converted to equity			(11,867)	(1,794)
Ending Balance				11,867
Other Loans
Debt Instrument [Line Items]
Beginning Balance			6,931	8,093
Loans advanced, net			930	509
Equity component				(1,168)
Loan payments			(357)	(685)
Accrued interest			854	182
Ending Balance			$ 8,358	$ 6,931	$ 8,093

Notes Payable and Convertible_4

Notes Payable and Convertible Notes - Summary of Classification of Notes Payable and Convertible Notes (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Long-term debt	$ 55,201	$ 67,015	$ 87,989
Less current portion	(6,539)	(5,024)
Long term portion	48,662	61,991
Gotham Green Partners LLC
Debt Instrument [Line Items]
Long-term debt			35,607
LI Lending, LLC
Debt Instrument [Line Items]
Long-term debt	46,843	45,362	44,289
Long term portion	46,843	45,362
May 2020 Convertible Notes
Debt Instrument [Line Items]
Long-term debt		2,855
Long term portion		2,855
May 2020 Convertible Notes (Swap)
Debt Instrument [Line Items]
Long-term debt		11,867
Long term portion		11,867
Other Loans
Debt Instrument [Line Items]
Long-term debt	8,358	6,931	$ 8,093
Less current portion	(6,539)	(5,024)
Long term portion	$ 1,819	$ 1,907

Notes Payable and Convertible_5

Notes Payable and Convertible Notes - Additional Information (Details)	Jan. 01, 2022USD ($)	May 28, 2020USD ($)Day$ / sharesshares	May 14, 2020USD ($)Day$ / shares	Jan. 29, 2020USD ($)$ / sharesshares	Mar. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Apr. 30, 2020USD ($)	Jun. 30, 2021USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	May 10, 2019USD ($)
Debt Instrument [Line Items]
Issuance of notes payable								$ 930,000	$ 9,146,000
Issued debt in exchange of convertible equity									13,661,000
Fair of convertible equity component									5,842,000
Other payables								$ 8,358
Gotham Green Partners LLC
Debt Instrument [Line Items]
Issuance of notes payable									2,810,000
Fair of convertible issued on acquisition										$ 39,881,000
Fair of convertible equity component									$ 692,000	$ 4,874,000
Gotham Green Partners LLC | Secured Debt
Debt Instrument [Line Items]
Interest rate, stated percentage				15.00%
Debt instrument, maturity date								Jul. 29, 2020
Debt instrument, convertible, conversion price | $ / shares				$ 0.64675
Debt instrument, interest rate terms				accrued interest at 15% per annum with no payments due until the maturity date.
Short term payables				$ 3,000,000
Convertible notes include number warrants to purchase shares | shares				2,230,080
Warrants purchase price per share | $ / shares				$ 0.672625
LI Lending, LLC
Debt Instrument [Line Items]
Interest rate, stated percentage							10.25%	10.25%
Maximum borrowing capacity under credit facility											$ 50,000,000
Amount drawn under credit facility								$ 45,000,000
Debt instrument, monthly interest-only payments					$ 35,000,000	$ 33,000,000	$ 33,000,000	35,000,000
Debt instrument, final interest-only payments						$ 10,000,000	10,000,000	10,000,000
Debt instrument, initial transaction costs								$ 806,000
Agreed prepayment principal for month							$ 250,000
Principal amount prepayment period							8 months
Prepayment beginning date							May 1, 2020
Additional Interest rate on final loan amount							12.25%
Debt prepayment							$ 2,000,000
Increase in interest rate						2.50%
Interest rate on initial loan amount						10.25%			10.25%
Interest rate on final loan amount						12.25%			12.25%
Credit facility maturity date								May 10, 2024
Percentage of exit fee of the principal balance								20.00%
LI Lending, LLC | Forecast
Debt Instrument [Line Items]
Debt instrument, monthly interest-only payments	$ 33,000,000
Debt instrument, final interest-only payments	$ 10,000,000
Interest rate on initial loan amount	12.75%
Interest rate on final loan amount	14.75%
Measurement Input, Discount Rate | Gotham Green Partners LLC
Debt Instrument [Line Items]
Debt Instrument, discount rate										10.25
May 2020 Convertible Notes
Debt Instrument [Line Items]
Issuance of notes payable			$ 5,827,000						$ 5,827,000
Interest rate, stated percentage			5.00%
Debt instrument, issuance date			May 14, 2020
Debt instrument, maturity date			Feb. 28, 2022
Debt instrument, convertible, conversion price | $ / shares			$ 0.25
Debt instrument, convertible, stock price trigger | $ / shares			$ 0.50
Debt instrument, convertible, threshold consecutive trading days | Day			45
Fair of convertible equity component									3,982,000
May 2020 Convertible Notes (Swap)
Debt Instrument [Line Items]
Debt instrument, maturity date								May 28, 2025
Debt instrument, convertible, conversion price | $ / shares		$ 0.46
Debt instrument, convertible, stock price trigger | $ / shares		$ 0.92
Debt instrument, convertible, threshold consecutive trading days | Day		45
Number of shares exchanged in debt | shares		29,448,468
Issued debt in exchange of convertible equity		$ 13,661,000							$ 13,661,000
Exchanged shares value		13,661,000
Debt instrument, interest rate terms								The notes pay no interest if the Company’s annual revenue is greater than $15,000, and 3% annually otherwise.
Minimum required annual revenue for interest payment		$ 15,000,000
Minimum required percentage of annual revenue for interest payment		3.00%

Notes Payable and Convertible_6

Notes Payable and Convertible Notes - Summary of Convertible Debt (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Total Notes Payable and Convertible Notes	$ 8,358	$ 6,931
Healthy Pharms Inc. | Convertible Note
Debt Instrument [Line Items]
Terms	Unsecured convertible note at $0.50 per share, due November 18, 2021 at 12% per annum
Total Notes Payable and Convertible Notes	$ 2,420	1,652
Healthy Pharms Inc. | Unsecured Debt
Debt Instrument [Line Items]
Terms	Unsecured promissory note, due November 18, 2021 at 12% per annum
Total Notes Payable and Convertible Notes	$ 2,905	2,823
Om of Medicine, LLC | Membership
Debt Instrument [Line Items]
Terms	Membership interest purchase agreement contingent payment due December 1, 2021 at 10% per annum
Total Notes Payable and Convertible Notes	$ 485
Arkansas Entities | Unsecured Debt | 14% Unsecured Promissory Note
Debt Instrument [Line Items]
Terms	Unsecured promissory note, monthly interest payments at 14% per annum
Total Notes Payable and Convertible Notes	$ 1,730	1,730
Equipment Loans | Secured Debt
Debt Instrument [Line Items]
Terms	Secured by equipment, monthly payments beginning in 2021 at 15% per annum
Total Notes Payable and Convertible Notes	$ 645	512
Other
Debt Instrument [Line Items]
Terms	Various
Total Notes Payable and Convertible Notes	$ 173	$ 214

Notes Payable and Convertible_7

Notes Payable and Convertible Notes - Summary of Convertible Debt (Parenthetical) (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Healthy Pharms Inc. | Convertible Note
Debt Instrument [Line Items]
Debt instrument, convertible, conversion price	$ 0.50	$ 0.50
Interest rate, stated percentage	12.00%	12.00%
Debt instrument, maturity date	Nov. 18, 2021	Nov. 18, 2021
Healthy Pharms Inc. | Unsecured Debt
Debt Instrument [Line Items]
Interest rate, stated percentage	12.00%	12.00%
Debt instrument, maturity date	Nov. 18, 2021	Nov. 18, 2021
Om of Medicine, LLC | Membership
Debt Instrument [Line Items]
Interest rate, stated percentage	10.00%
Debt instrument, maturity date	Dec. 1, 2021
Arkansas Entities | Unsecured Debt | 14% Unsecured Promissory Note
Debt Instrument [Line Items]
Interest rate, stated percentage	14.00%	14.00%
Equipment Loans | Secured Debt
Debt Instrument [Line Items]
Interest rate, stated percentage	15.00%	15.00%
Debt monthly payment beginning year	2021	2021

Notes Payable and Convertible_8

Notes Payable and Convertible Notes - Summary of Future Minimum Payments of Notes and Convertible Notes (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Debt Disclosure [Abstract]
2021	$ 5,498
2022	1,730
2024	53,180
Total minimum payments	60,408
Effect of discounting	(5,207)
Long-term debt	55,201	$ 67,015	$ 87,989
Less current portion	(6,539)	(5,024)
Long term portion	$ 48,662	$ 61,991

Share Capital and Equity - Addi

Share Capital and Equity - Additional Information (Details) $ in Thousands	Nov. 23, 2020USD ($)shares	Jun. 30, 2021USD ($)$ / shares	Jun. 30, 2021USD ($)$ / shares	Nov. 23, 2020$ / shares
Class Of Stock [Line Items]
Change in fair value of derivative liability | $		$ 311	$ 2,843
Option Pricing Model
Class Of Stock [Line Items]
Warrants classified as derivative liability value | $	$ 4,229
Expected Life	2 years	1 year 4 months 24 days	1 year 4 months 24 days
Option Pricing Model | Share Price
Class Of Stock [Line Items]
Warrants measurement input		1.56	1.56	0.94
Option Pricing Model | Exercise Price
Class Of Stock [Line Items]
Warrants measurement input				0.90
Option Pricing Model | Annualized Volatility
Class Of Stock [Line Items]
Warrants measurement input	87.73	86.2	86.2
Option Pricing Model | Dividend Yield
Class Of Stock [Line Items]
Warrants measurement input	0	0	0
Option Pricing Model | Measurement Input, Discount Rate
Class Of Stock [Line Items]
Warrants measurement input	0.16	0.07	0.07
Option Pricing Model | Exchange Rate
Class Of Stock [Line Items]
Warrants measurement input		1.24	1.24	1.31
Deal Prospectus Offering
Class Of Stock [Line Items]
Share capital units description			Each Unit is comprised of one SVS of the Company and one-half of a SVS purchase warrant.
Number of voting shares for each unit | shares	1
Number of warrants for each unit | shares	1.5
Number of shares called by each warrant | shares	1
Class of warrant year from which warrants exercisable	2 years
Warrants purchase price per share				$ 0.90
Net proceeds from issuance of stock with warrants | $	$ 11,557
Payments of share issuance costs | $	$ 690
Deal Prospectus Offering | Share Capital with Unit Price of C$0.70
Class Of Stock [Line Items]
Units issued | shares	24,644,500
Units issued, price per unit				$ 0.70
Class A Subordinate Voting Shares
Class Of Stock [Line Items]
Description of rights attached to each class of capital			one vote
Class C Multiple Voting Shares
Class Of Stock [Line Items]
Description of rights attached to each class of capital			800
Number of shares into which each class of another share is convertible		0	0
Percentage of shares of one class held as a percentage of shares of another class		50.00%	50.00%
Period when the convertibility of shares from one class to another become exercisable			3 years

Share Capital and Equity - Summ

Share Capital and Equity - Summary of Share Capital and Equity (Details)	Jun. 30, 2021shares
Class Of Stock [Line Items]
Number of shares outstanding	593,898,521
Class A Shares
Class Of Stock [Line Items]
Number of shares outstanding	592,622,313
Class C Shares
Class Of Stock [Line Items]
Number of shares outstanding	1,276,208
Class A Subordinate Voting Shares
Class Of Stock [Line Items]
Number of shares outstanding	592,622,313
Class C Multiple Voting Shares
Class Of Stock [Line Items]
Number of shares outstanding	1,276,208

Warrants - Additional Informati

Warrants - Additional Information (Details) - shares	Jun. 30, 2021	Dec. 31, 2020
Warrants And Rights Note Disclosure [Abstract]
Share purchase warrants outstanding	39,779,765	42,772,992

Warrants - Summary of Warrants

Warrants - Summary of Warrants Outstanding to Purchase Shares (Details)	6 Months Ended
	Jun. 30, 2021$ / sharesshares
Warrants And Rights Note Disclosure [Abstract]
Number of warrants, Beginning balance | shares	42,772,992
Number of warrants, Exercised | shares	(2,993,227)
Number of warrants, Ending balance | shares	39,779,765
Weighted average exercise price, Beginning balance | $ / shares	$ 0.90
Weighted average exercise price, Exercised | $ / shares	0.68
Weighted average exercise price, Ending balance | $ / shares	$ 0.92

Warrants - Summary of Warrant_2

Warrants - Summary of Warrants Outstanding And Exercisable (Details)	Jun. 30, 2021$ / sharesshares	Jun. 30, 2021$ / sharesshares	Dec. 31, 2020shares
Class Of Warrant Or Right [Line Items]
Warrants Outstanding	39,779,765	39,779,765	42,772,992
Exercise Price $1.00
Class Of Warrant Or Right [Line Items]
Warrants Outstanding	7,000,000	7,000,000
Exercise Price | $ / shares	$ 1
Expiry Date	Nov. 21, 2021	Nov. 21, 2021
Exercise Price $1.33
Class Of Warrant Or Right [Line Items]
Warrants Outstanding	4,511,278	4,511,278
Exercise Price | $ / shares	$ 1.33
Expiry Date	Nov. 21, 2021	Nov. 21, 2021
Exercise Price $1.99
Class Of Warrant Or Right [Line Items]
Warrants Outstanding	2,010,050	2,010,050
Exercise Price | $ / shares	$ 1.99
Expiry Date	Nov. 21, 2021	Nov. 21, 2021
Exercise Price CAD 0.90
Class Of Warrant Or Right [Line Items]
Warrants Outstanding	10,469,350	10,469,350
Exercise Price | $ / shares		$ 0.90
Expiry Date	Nov. 23, 2022	Nov. 23, 2022
Exercise Price CAD 0.70
Class Of Warrant Or Right [Line Items]
Warrants Outstanding	298,085	298,085
Exercise Price | $ / shares		$ 0.70
Expiry Date	Nov. 23, 2022	Nov. 23, 2022
Exercise Price $0.82
Class Of Warrant Or Right [Line Items]
Warrants Outstanding	12,135,922	12,135,922
Exercise Price | $ / shares	$ 0.82
Expiry Date	Dec. 17, 2022	Dec. 17, 2022
Exercise Price $0.67
Class Of Warrant Or Right [Line Items]
Warrants Outstanding	2,230,080	2,230,080
Exercise Price | $ / shares	$ 0.67
Expiry Date	Jan. 29, 2023	Jan. 29, 2023
Exercise Price CAD 0.80
Class Of Warrant Or Right [Line Items]
Warrants Outstanding	625,000	625,000
Exercise Price | $ / shares		$ 0.80
Expiry Date	Oct. 6, 2024	Oct. 6, 2024
Exercise Price CAD 0.80
Class Of Warrant Or Right [Line Items]
Warrants Outstanding	500,000	500,000
Exercise Price | $ / shares		$ 0.80
Expiry Date	Oct. 6, 2025	Oct. 6, 2025

Share-Based Compensation - Addi

Share-Based Compensation - Additional Information (Details) - Equity Incentive Plan - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Recognized share-based compensation expense	$ 2,979	$ 684	$ 5,375	$ 2,276
Class A Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Maximum number of stock options available for grant, percentage of number of outstanding shares			10.00%
Minimum exercise price of stock options issued, percentage of fair market value of shares on grant date			100.00%
Maximum term of stock options granted			5 years

Share-Based Compensation - Summ

Share-Based Compensation - Summary of Options Outstanding and Exercisable on an As-Converted Basis (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options Outstanding	56,291,009	50,427,065	40,028,465
Life Remaining (years)	3 years 5 months 26 days	3 years 8 months 19 days	4 years 1 month 13 days
Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options Outstanding	56,291,009
Exercisable Options	31,381,068
Life Remaining (years)	3 years 5 months 26 days
Stock Options Granted on July 31, 2019, One | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 1
Options Outstanding	7,983,332
Exercisable Options	7,983,332
Life Remaining (years)	1 year 5 months 12 days
Stock Options Granted on July 31, 2019, Two | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 1
Options Outstanding	1,166,667
Exercisable Options	1,166,667
Life Remaining (years)	2 years 3 months 7 days
Stock Options Granted on July 31, 2019, Three | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 1.50
Options Outstanding	516,666
Exercisable Options	516,666
Life Remaining (years)	2 years 11 months 12 days
Stock Options Granted on July 31, 2019, Four | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 1.50
Options Outstanding	800,000
Exercisable Options	333,334
Life Remaining (years)	2 years 11 months 19 days
Stock Options Granted on July 31, 2019, Five | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 0.10
Options Outstanding	6,245,840
Exercisable Options	6,245,840
Life Remaining (years)	3 years 2 months 15 days
Stock Options Granted on August 22, 2019, One | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 0.80
Options Outstanding	6,150,000
Exercisable Options	1,881,450
Life Remaining (years)	3 years 1 month 24 days
Stock Options Granted on August 22, 2019, Two | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 1
Options Outstanding	5,850,104
Exercisable Options	2,772,913
Life Remaining (years)	3 years 1 month 24 days
Stock Options Granted on November 1, 2019 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 0.80
Options Outstanding	1,200,000
Exercisable Options	400,000
Life Remaining (years)	3 years 4 months 2 days
Stock Options Granted on February 3, 2020 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 0.80
Options Outstanding	425,000
Exercisable Options	158,333
Life Remaining (years)	3 years 7 months 6 days
Stock Options Granted on June 8, 2020 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 0.80
Options Outstanding	25,000
Exercisable Options	8,333
Life Remaining (years)	3 years 7 months 6 days
Stock Options Granted on July 31, 2020 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 0.80
Options Outstanding	1,200,000
Exercisable Options	1,500,000
Life Remaining (years)	4 years 1 month 2 days
Stock Options Granted on September 15, 2020 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 0.86
Options Outstanding	7,978,400
Exercisable Options	3,689,200
Life Remaining (years)	4 years 2 months 15 days
Stock Options Granted on October 2, 2020 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 0.77
Options Outstanding	3,000,000
Exercisable Options	1,500,000
Life Remaining (years)	4 years 3 months 3 days
Stock Options Granted on November 24, 2020 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 0.94
Options Outstanding	1,775,000
Exercisable Options	1,775,000
Life Remaining (years)	4 years 4 months 28 days
Stock Options Granted on December 2, 2020 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 1.11
Options Outstanding	2,900,000
Exercisable Options	1,450,000
Life Remaining (years)	4 years 5 months 4 days
Stock Options Granted on December 21, 2020 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 1.06
Options Outstanding	1,200,000
Life Remaining (years)	4 years 5 months 23 days
Stock Options Granted on March 18, 2021 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 1.63
Options Outstanding	6,850,000
Life Remaining (years)	4 years 8 months 19 days
Stock Options Granted on April 2, 2021 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 1.36
Options Outstanding	200,000
Life Remaining (years)	4 years 8 months 19 days
Stock Options Granted on April 21, 2021 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 1.58
Options Outstanding	175,000
Life Remaining (years)	4 years 8 months 19 days
Stock Options Granted on June 23, 2021 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 1.56
Options Outstanding	450,000
Life Remaining (years)	4 years 11 months 23 days
Stock Options Granted on June 28, 2021 | Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Strike Price	$ 1.57
Options Outstanding	200,000
Life Remaining (years)	5 years

Share-Based Compensation - Su_2

Share-Based Compensation - Summary of Stock Option Activity (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Number of Options, Beginning Balance	50,427,065	40,028,465
Number of Options, Granted	7,875,000	19,190,960
Number of Options, Exercised	(2,011,056)
Number of Options, Forfeited		(8,792,360)
Number of Options, Ending Balance	56,291,009	50,427,065	40,028,465
Weighted Average Price, Beginning Balance	$ 0.84	$ 0.86
Weighted Average Price, Granted	1.63	0.90
Weighted Average Price, Exercised	0.93
Weighted Average Price, Forfeited		1.04
Weighted Average Price, Ending Balance	$ 0.94	$ 0.84	$ 0.86
Weighted Average Years	3 years 5 months 26 days	3 years 8 months 19 days	4 years 1 month 13 days
Weighted Average Years,Granted	4 years 11 months 19 days
Weighted Average Years,Exercised	4 years 11 months 19 days

Share-Based Compensation - Su_3

Share-Based Compensation - Summary of Stock Options Values using Black-Scholes Model with Key Assumptions (Details) - Equity Based Compensation Options - 4Front Holdings LLC	6 Months Ended
	Jun. 30, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Risk-Free Interest Rate, minimum	0.87%
Risk-Free Interest Rate, maximum	0.92%
Expected Life of Options (years)	5 years
Expected Annualized Volatility, minimum	86.20%
Expected Annualized Volatility, maximum	93.53%
Expected Dividend Yield

Related Parties - Additional In

Related Parties - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	May 10, 2019
Pure Ratios | Online CBD Market
Related Party Transaction [Line Items]
Revenue from services to related party			$ 313	$ 2,334
7Point Holdings LLC
Related Party Transaction [Line Items]
Commercial sublease expiration date			May 31, 2023
Commercial sublease, renewal option description			one five-year renewal option
Commercial sublease, renewal term			5 years
Interest revenue on lease receivable	$ 725	$ 751	$ 1,459	$ 1,507
LI Lending, LLC
Related Party Transaction [Line Items]
Outstanding amount under credit facility	$ 46,843		$ 46,843		$ 50,000

Contingencies - Summary of Fair

Contingencies - Summary of Fair Value of Contingent Consideration (Details) - Om of Medicine $ in Thousands	6 Months Ended
	Jun. 30, 2021USD ($)
Loss Contingencies [Line Items]
Balance, December 31, 2020	$ 5,496
Accretion	228
Payments	(1,201)
Notes issued	(485)
Shares issued	(722)
Balance, June 30, 2021	$ 3,316

Contingencies - Additional Info

Contingencies - Additional Information (Details) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2021USD ($)Claim	Jun. 30, 2020USD ($)	Jun. 30, 2021USD ($)Claim	Jun. 30, 2020USD ($)	Dec. 31, 2020USD ($)
Loss Contingencies [Line Items]
Revenues	$ 27,121	$ 12,701	$ 50,091	$ 25,353
Number of pending lawsuits | Claim	0		0
Om of Medicine | Revenue Milestone One | Minimum
Loss Contingencies [Line Items]
Revenues					$ 3,400
Om of Medicine | Revenue Milestone One | Maximum
Loss Contingencies [Line Items]
Business combination contingent consideration payable	$ 6,000		$ 6,000

Financial Instruments and Fin_2

Financial Instruments and Financial Risk Management - Additional information (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Investments All Other Investments [Abstract]
Fair value, assets, level 1 to level 2 transfers, amount	$ 0	$ 0
Fair value, assets, level 2 to level 1 transfers, amount	0	0
Fair value, liabilities, level 1 to level 2 transfers, amount	0	0
Fair value, liabilities, level 2 to level 1 transfers, amount	0	0
Fair value, equity, level 1 to level 2 transfers, amount	0	0
Fair value, equity, level to level 1 transfers, amount	0	0
Fair value, transfers into (out of) level 3	0	0
Federally insured limits exceeded amount	5,000,000	$ 5,000,000
Cash held with bank accounts	1,121,000
Maximum credit exposure	$ 12,431,000

Segment Information - Additiona

Segment Information - Additional Information (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2021USD ($)Segment	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Segment Information [Line Items]
Number of reportable segments | Segment	2
Goodwill	$ 23,155	$ 23,155	$ 40,283
Intangible assets, net	27,524	28,790
THC Cannabis
Segment Information [Line Items]
Goodwill	23,155	23,155
Intangible assets, net	27,524	28,790
CBD Wellness
Segment Information [Line Items]
Goodwill	0	0
Intangible assets, net	$ 0	$ 0

Segment Information - Summary o

Segment Information - Summary of Revenues By Type (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Segment Reporting Information [Line Items]
Total Net Revenues	$ 27,121	$ 12,701	$ 50,091	$ 25,353
Total Depreciation and Amortization	861	$ 975	1,635	1,888
Total Assets	208,764		208,764		$ 204,756
THC Cannabis
Segment Reporting Information [Line Items]
Total Net Revenues			48,544	21,894
Total Depreciation and Amortization			1,589	1,847
Total Assets	201,091		201,091		186,899
CBD Wellness
Segment Reporting Information [Line Items]
Total Net Revenues			1,547	3,459
Total Depreciation and Amortization			16	$ 41
Total Assets	1,815		1,815		2,198
Corporate
Segment Reporting Information [Line Items]
Total Depreciation and Amortization			30
Total Assets	$ 5,858		$ 5,858		$ 15,659

Supplementary Cash Flow Infor_3

Supplementary Cash Flow Information - Summary of Changes in Non-Cash Working Capital (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Changes in operating assets and liabilities
Accounts receivable	$ (815)	$ 33
Deposits	(70)
Inventory	(4,563)	(2,616)
Prepaid expenses	50	360
Accounts payable and other liabilities	65	(2,501)
Taxes payable	5,163	2,636
Changes in operating assets and liabilities	$ (170)	$ (2,088)

Supplementary Cash Flow Infor_4

Supplementary Cash Flow Information - Additional Information (Details) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Supplemental Cash Flow Information [Abstract]
Cash paid for interest	$ 1,662,000	$ 3,765,000
Cash paid for income taxes	$ 224,000	$ 0

Income Taxes - Summary of Incom

Income Taxes - Summary of Income Tax Expense and Effective Tax Rates (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Net loss before income taxes	$ (11,298)	$ (5,096)
Income tax expense	$ (6,004)	$ (3,335)
Effective tax rate	(53.14%)	(65.44%)

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details)	6 Months Ended
	Jun. 30, 2021
Federal Statute of Limitation
Income Taxes [Line Items]
Open tax year	2017
State Income Tax Returns
Income Taxes [Line Items]
Open tax year	2016

Disposals and Discontinued Op_3

Disposals and Discontinued Operations - Additional Information (Details) $ in Thousands	Sep. 30, 2020Dispensary	Mar. 20, 2020USD ($)	Jan. 29, 2020USD ($)Company
Two Management Companies
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Number of management companies sold | Company			2
Consideration			$ 2,000
Net income from discontinued operations			$ 2,000
PHX Interactive LLC and Control of Greens Goddess Inc.
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Consideration		$ 6,000
Fee paid to lender		$ 348
Maryland Management Companies
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Number of additional dispensaries | Dispensary	3

Disposals and Discontinued Op_4

Disposals and Discontinued Operations - Summary of Net Income or Loss from Discontinued Operations (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2020
Discontinued Operations And Disposal Groups [Abstract]
REVENUE	$ 4,423	$ 9,421
Cost of goods sold	(2,791)	(6,107)
Gross profit	1,632	3,314
OPERATING EXPENSES
Selling and marketing expenses	1,270	3,007
Depreciation and amortization		353
Gain on sale of subidiary	(9,559)	(11,211)
Total operating (income) expenses	(8,289)	(7,851)
Income from operations	9,921	11,165
Interest expense	(42)	(41)
Net income before income taxes	9,879	11,124
Income tax expense	(39)	(412)
Net income after income tax expense	$ 9,840	$ 10,712

Disposals and Discontinued Op_5

Disposals and Discontinued Operations - Summary of Cash Flows Generated by Discontinued Operations (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2020USD ($)
Discontinued Operations And Disposal Groups [Abstract]
Net cash provided by discontinued operation activities	$ 7,107
Net cash used in discontinued investing activities	(59)
Cash flows from discontinued operations	$ 7,048

Subsequent Events - Additional

Subsequent Events - Additional Information (Details) - Subsequent Event	Aug. 05, 2021ft²BrandProduct
Subsequent Event [Line Items]
Number of in-house brands to be produced in facility | Brand	20
Number of products to be produced in facility | Product	200
Maximum
Subsequent Event [Line Items]
Area of land used to build cultivation and production facility | ft²	558,000